Digital Pathology Display
PZZ is the FDA product code for Digital Pathology Display, a class II device type, regulated under 21 CFR 864.3700. FDA's definition for this code reads: "The digital pathology display device is intended for in vitro diagnostic use to display digital images of histopathology slides acquired from FDA-cleared whole-slide imaging scanners that are used for review and interpretation by trained pathologists". As of , FDA records hold 3 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- PZZ
- Device name
- Digital Pathology Display
- FDA definition
- The digital pathology display device is intended for in vitro diagnostic use to display digital images of histopathology slides acquired from FDA-cleared whole-slide imaging scanners that are used for review and interpretation by trained pathologists.
- Regulation
- 21 CFR 864.3700
- Device class
- Class II
- Review panel
- Pathology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 3
- Ingested recalls
- 0
Clearances, product code PZZ
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2017 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Applicants with the most clearances
Product code PZZ| Applicant | Clearances |
|---|---|
| Barco N.V. | 1 |
| Eizo Corporation | 1 |
| Shenzhen Beacon Display Technology Co., Ltd. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
